Literature DB >> 9642071

Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus.

J M McDonnell1, D Fushman, S M Cahill, W Zhou, A Wolven, C B Wilson, T D Nelle, M D Resh, J Wills, D Cowburn.   

Abstract

A biologically active construct of the retroviral M domain from the avian Rous sarcoma virus is defined and its solution structure described. This M domain is fully active in budding and infectivity without myristylation. In spite of a sequence homology level that suggests no relationship among M domains and the family of matrix proteins in mammalian retroviruses, the conserved structural elements of a central core allow an M domain sequence motif to be described for all retroviruses. The surface of the M domain has a highly clustered positive patch comprised of sequentially distant residues. An analysis of the backbone dynamics, incorporating rotational anisotropy, is used to estimate the thermodynamics of proposed domain oligomerization. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642071     DOI: 10.1006/jmbi.1998.1788

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

2.  Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.

Authors:  S M Joshi; V M Vogt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Authors:  Jany Chan; Robert A Dick; Volker M Vogt
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

6.  Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.

Authors:  Lisa Z Scheifele; Jonathan D Rhoads; Leslie J Parent
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly.

Authors:  Gwen M Taylor; Lixin Ma; Volker M Vogt; Carol Beth Post
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

Review 8.  Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.

Authors:  Leslie J Parent; Nicole Gudleski
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

9.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Analysis of bovine leukemia virus gag membrane targeting and late domain function.

Authors:  Huating Wang; Kendra M Norris; Louis M Mansky
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.